Company intelligence / Profile preview

CESS

Ownership: Private
Development stage: Other

Overview

CESS provides privacy-centric decentralized storage, combining blockchain and advanced cryptography to ensure secure, sovereign data sharing and management. It enables federated learning for AI and supports multiple industries, but no clinical trial or drug development results are available.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Web3 Foundation (grants)Anon ID (identity solution)TellyWelly (decentralized streaming)

Beyond the preview

Go deeper on CESS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CESS.

Explore the full profile